Lethal toxicity is a condition induced in mice by intraperitoneal (i.p.) injections of approximately 3 x 1010 colony-forming units (CFU) of recent isolates of Mycoplasma fermentans (7, 10) . Signs of the disease include ruffled fur, diarrhea, anorexia, matted eyes, and huddling. Histopathological alterations include hepatocellular necrosis, thymic involution, splenic congestion, and an intravascular accumulation of leukocytes in the lungs. Death normally occurs within 48 h after injection.
This experimental disease is unique since it is induced in mice by a supposedly nonpathogenic, human mycoplasma species, and also because some of its manifestations resemble those of endotoxic shock. For example, the microscopic pathology of lung and thymus (7, 18, 23) , the mucoid diarrhea (7, 23) , and the potentiation by antitumor drugs which inhibit protein synthesis (9) are seen in both mycoplasma-induced lethal toxicity and gram-negative endotoxemia.
The mode of action of M. fermentans in lethal toxicity is not clear. In endotoxemia, however, it is known that lysosomal acid hydrolases are markedly increased and that these have potential for some direct or indirect role in pathogenesis (15, 26) . In light of these observations and the significant tissue necrosis accompanying lethal toxicity, it appeared that lysosomal enzymes could also have a role in this mycoplasma disease. The following study was designed to evaluate the effects of mycoplasma-induced lethal toxicity on lysosomal enzymes in mouse tissues, with acid phosphatase and betaglucuronidase as indicators of acid hydrolase activity (2, 3, 13, 24) .
MATERIALS AND METHODS
Mycoplasma. The origin of M. fermentans, strain K10, and methods of cultivation and enumeration have been described previously (7, 9, 10) . Cultures were grown to peak log phase in 500-to 1,000-ml lots and were collected by centrifugation at 12,000 x g for 20 min. Cells were washed two times in phosphate-buffered saline (PBS), pH 6.8, and were resuspended in PBS to yield approximately 3 x 1010 CFU per 1.0-ml intraperitoneal injection. In each experi- were not dose dependent, since higher concentrations of cells resulted in lower enzyme levels.
However, levels on beta-glucurondiase were affected ( Table 2) . Endotoxin gave minor changes in liver, spleen, and thymus, while serum levels increased at least 30%. M. fermentans caused even higher increases. Levels in liver increased 40 to 60% and were dose dependent, while near-toxic doses of mycoplasmas raised the serum beta-glucuronidase activity threefold. (Fig. 2) . Peak activity of 30.8 (gmol of phenolphthalein released per ml per h) was reached at 8 h, after which the level of beta-glucuronidase fell to 18.9 relative to the zero-time control value of 5.1. The betaglucuronidase level was at least two times the control level at each time point examined, and the maximum level at 8 h was sixfold the control when mice were injected with M.
fermentans.
Assay reproducibility. To determine the reproducibility of the enzyme measurements and the accuracy of these high levels, 72 mice in two experiments were injected with 1.0 ml of VOL. 12, 1975 on August 27, 2017 by guest http://iai.asm.org/ Downloaded from PBS (control) or approximately 3 x 1010 CFU of M. fermentans K10. Mice were sacrificed in groups of three to five after 8 h, and serum levels of acid phosphatase and beta-glucuronidase were determined. The data represented in Fig. 3 indicate that values were consistent and repeatable, even between experiments with separate inocula. For acid phosphatase, the mean value was 2.68 units, with the standard error of the mean equal to 0.299 and standard deviation equal to 0.944 in PBS controls. In K10-treated mice, the mean acid phosphatase level was 2.99 units, with a standard error of the mean equal to 0.36 and a standard deviation of 1.08.
As anticipated, the beta-glucuronidase levels were markedly increased in mice treated with M. fermentans. The Mean data on 60 mice from two separate experiments are presented in Tables 3 and 4 . In endotoxin-treated animals, pretreatment with BCG resulted in a 40 to 50% increase over the levels seen with endotoxin alone, with the potentiation seen in both acid phosphatase and beta-glucuronidase. However, in mice injected with M. fermentans, enzyme levels were only raised when no BCG was administered. If mice were injected with BCG prior to the mycoplasma injection, the levels of both. acid phos- (25) .
The observation that tissue and serum levels of these enzymes are often markedly increased in certain disease states prompted speculation that they may participate in pathogenic processes. Data are available on levels of lysosomal enzymes in numerous diseases, including mucopolysaccharide storage disease (16) , ischemic trauma (12) , Chediak-Higashi syndrome (4), Pompe's disease (25) , and chlamydial shock (14, 15, 23, 24) . Actual responses varied with the endotoxin source, tissue, enzyme, and time and route of injection, but significant increases were generally noted. For example. Janoff et sil. (15) noted a twofold rise in serum acid phosphatase and beta-glucuronidase (4 h after SalmoneLla LPS intravenously in mice).
The current study analyzed host enzyme levels in response to toxic doses of M. fermentans K10 because the disease ("lethal toxicity" of mice) has some similarities to endotoxic shock and chlamydial shock. When mice were injected i.p. with approximately 3 x 1010 CFU of washed mycoplasma cells, tissue and serum levels of acid phosphatase ( Table 1 , Fig. 1) were near normal or only slightly increas'ed. However, beta-glucuronidase levels ( Table 2 , Fig. 2  and 3 ) immediately rose to a significant level. In serum, the effect was especially pronounced. Activity peaked at 8 h, with a specific activity six times that of the controls. Data collected on positive controls (E. coli LPS) and replicate experiments indicate that assay methods were accurate and reproducible. Actual results and standard deviations were consistent with other published reports (e.g., references 14 and 20).
Whether or not the source of the serum enzymes is necrotic solid tissue remains to be determined. It is conceivable that the enzymes are derived from components of the reticuloendothelial system involved with the phagocytosis of mycoplasmas.
Reasons for the low acid phosphatase activity with high beta-glucuronidase activity are obscure but could be related to differences in binding or, as suggested by Saito and Suter (19) , to differences in degree of release or genetic control of intracellular location which could affect speed of release. The observed differences in enzyme levels may also be a reflection of the differences in inactivation rates encountered in vivo outside of the lysosomal membrane. One must also consider the possibility that these proteins simply have different half-lives.
Pretreatment with BCG vaccine resulted in a potentiation of the enzymatic response'of mice injected with endotoxin. Levels of betaglucuronidase rose to 144% of the control values, and acid phosphatase levels were also raised (141% of controls). This is consistent with other reports (19) (20) (21) which indicate the' BCG markedly increased the sensitivity of mice to endotoxic shock and caused significant increases in the anticipated elevations of lysosomal enzyme activity, apparently through a nonimmunological mechanism (5). The fact that BCG pretreatment did not potentiate the enzymatic response to mycoplasmas (Tables 3 and  4) indicates that the lysosomal effect is proba-bly induced via different mechanisms in endotoxemia and in lethal toxicity.
Separate mechanisms would also be in accordance with another report (8) which demonstrated that mycoplasma-induced lethal toxicity does not arise as a result of leakage of gram-negative organisms or endotoxins from the gut. This conclusion was based on the absence of detectable organisms and toxin in serum or the peritoneum and on the ability to induce the disease in germfree mice. Collectively, the available data suggest that the similarity in host response for endotoxic shock and lethal toxicity is largely coincidental. This is not surprising since it is known that septic shock due to gram-negative and gram-positive organisms involves the same basic physiological responses (11) .
The precise role of the lysosomal enzymes in the mycoplasma-related pathogenic process is unclear. Elevations in beta-glucuronidase were consistent and statistically significant, but as with endotoxin-associated rises in enzymatic activity, it is not understood whether the elevation is primary or secondary, i.e., cause or effect of tissue necrosis. A potential mechanism can be envisioned whereby mycoplasmas, known for their affinity for biological membranes, could bind the cell membrane or to the lysosomal membrane (after penetration or engulfment) and perturb membrane integrity.
Further experiments should now be conducted to determine the number of lysosomal enzymes involved and to establish whether or not increases in activity are simply due to increases in the number of lysosomes. It also remains to be seen if the mycoplasmas, directly or indirectly, affect the fragility of lysosomes, or if they promote leakage through a weakened but intact membrane. In any event, it seems obvious that the participation of the lysosome should now be evaluated in several of the available animal models of mycoplasma infections since it could play a key role in pathogenesis. 
